Sunday, 26 August

LivaNova Satellite Symposium, 16:30-18:00, Strauss
Title: Where is the potential? Measuring the effect of neuromodulation

 

Chair: Kristl Vonck (Belgium)
De-syncing the cortex? Investigating VNS mechanisms with quantitative EEG methods Fabrice Bartolomei (France)
Learning from depression: insights from functional imaging of neurostimulation Charles Conway (USA)
A prestimulation evaluation protocol for patients with drug resistant epilepsy Kristl Vonck (Belgium)

 

mXm Medical Communications (supported by an educational grant from Eisai Europe Ltd) Satellite Symposium
16:30-18:00, Stolz
Title: How do we make evidence-based decisions for epilepsy patients excluded from randomised controlled trials?

Chair: Martin Holtkamp (Germany)
Psychiatric comorbidities in epilepsy: importance of early diagnosis and a multidisciplinary approach to care Sophie Dupont (France)
Management of epilepsy during pregnancy: what is best practice? Torbjörn Tomson (Sweden)
Treatment of epilepsy in the elderly: the need for real-world evidence Vicente Villanueva (Spain)

 

Monday, 27 August

GW Pharmaceuticals Satellite Symposium, 16:30-18:00, Stolz
Title: The Challenge of Improving Treatment for Patients Living With Epileptic Encephalopathies From Childhood to Adulthood

Chair: Eugen Trinka (Austria)
Regulatory Pathways, Rare Diseases and Rethinking Epileptic Encephalopathies Michel Baulac (France)
Current Therapeutic Options and Future Opportunities Emilio Perucca (Italy)
Diagnosis, Assessment and Care of Epileptic Encephalopathies into Adulthood Thomas Mayer (Germany)

 

 

Tuesday, 28 August

MEGIN Satellite Symposium, 08:00-09:30, Schubert 4
Title: Application of MEG in epilepsy and its impact on patient outcome:
A joint symposium of EMEGS and MEGIN an Elekta company

Chair: Paul Boon, Belgium
Clinical MEG application in lesional and nonlesional epilepsies Hermann Stefan (Germany)
Electromagnetic source imaging: a prospective study of diagnostic accuracy and clinical utility in presurgical evaluation Sándor Beniczky (Denmark)
Impact of MEG on epilepsy surgery outcome Karl Rössler (Germany)

 

Zogenix Satellite Symposium, 16:30-18:00, Stolz
Title: Dravet Syndrome: how can we better inform and shape future management?

Co-chairs: Renzo Guerrini (Italy) & Elaine Wirrell (USA)
DS and other sodium channelopathies: genotypes, phenotypes and treatment response Andreas Brunklaus (United Kingdom)
Impact beyond seizures: evaluating the burden Adam Strzelczyk (Germany)
Clinical decision making: key considerations Catherine Chiron (France)
Shaping future management Rima Nabbout (France)

 

Eisai Satellite Symposium, 16:30-18:00, Strauss 1
Title: Epilepsy in 2030: what can we expect?

Chair: Eugen Trinka (Austria)
Epilepsy trends and priorities for the future Eugen Trinka (Austria)
Evolving epilepsy populations and changing goalposts Matthew Walker (United Kingdom)
The connected patient: monitoring seizures and beyond  Philippe Ryvlin (Switzerland)
Personalized and precision medicine for epilepsy in 2030 Patrick Kwan (Australia)

 

 

Wednesday, 29 August

Epilog Satellite Symposium, 08:00-09:30, Schubert 4
Title: Update on ictal and interictal EEG source localization to identify the epileptogenic zone

Chair: Margitta Seeck (Switzerland)
a) Automated EEG source imaging: a retrospective, blinded clinical validation study
b) Epicare – prospective evaluation of ESI
Sándor Beniczky (Denmark)
Case Discussion Gudrun Kalss (Austria)
Susana Ferrao Santos (Belgium)
Prospective studies in ESI: clinical impact Margitta Seeck (Switzerland)
Ictal EEG source localization Pieter van Mierlo (Belgium)

 

Novartis Satellite Symposium, 16:30-18:00, Stolz
Title: Management of Seizures in Patients with TSC

Chair: Martha Feucht (Austria)
Welcome and introduction Martha Feucht (Austria)
Tuberous sclerosis: a complex disease Vicente Villanueva (Spain)
Considerations for management of TSC and TSC-related seizures Matthias Koepp (United Kingdom)
Adjunctive everolimus therapy for the treatment of refractory seizures associated with TSC: Final results from the EXIST-3 trial Tilman Polster (Germany)